Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer.

MLA

Soberanis Pina, Pamela, et al. “Case Report: Osimertinib Administration during Pregnancy in a Woman with Advanced EGFR-Mutant Non-Small Cell Lung Cancer.” Frontiers in Oncology, vol. 13, Mar. 2023, p. 1108124. EBSCOhost, https://doi.org/10.3389/fonc.2023.1108124.

APA

Soberanis Pina, P., Lara-Mejía, L., Matias-Cruz, V., Barrón, F., Cardona, A. F., Raez, L. E., Rios-Garcia, E., & Arrieta, O. (2023). Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer. Frontiers in Oncology, 13, 1108124. https://doi.org/10.3389/fonc.2023.1108124

Chicago

Soberanis Pina, Pamela, Luis Lara-Mejía, Venecia Matias-Cruz, Feliciano Barrón, Andrés F Cardona, Luis E Raez, Eduardo Rios-Garcia, and Oscar Arrieta. 2023. “Case Report: Osimertinib Administration during Pregnancy in a Woman with Advanced EGFR-Mutant Non-Small Cell Lung Cancer.” Frontiers in Oncology 13 (March): 1108124. doi:10.3389/fonc.2023.1108124.